|Last Price$32.43||Day Change (%)-0.09%|
|Open Price$32.51||Day Change ($)-0.03|
|Day Range32.18–32.66||52-Week Range27.12–32.96|
As of Fri 03/07/2014 04:38 PM EST | USD
Good day, everyone and welcome to Pfizer's Fourth Quarter 2013 Earnings Conference Call. Today's call is being recorded.
Australia Regulator Takes Action Against Pfizer Australia Over Cholesterol Drug
Australia Regulator Takes Action Against Pfizer Australia
Auxilium Pharmaceuticals Announces Fourth Quarter And Full Year 2013 Financial Results And Guidance For 2014
Pfizer's PFE new CEO, Jeff Kindler, wasted no time in implementing a new management structure, announced Tuesday. While this doesn't affect our fair value estimate, we think Pfizer could be losing some key talent in the process. Kindler restructured the world's largest pharmaceutical company into a ...
RXi Pharmaceuticals to Present at the 24th Annual Wall Street Analyst Forum
Research and Markets: Global Adult Vaccines Market Report 2013-2020: Company Adult Vaccines Sales & Country Adult Vaccines
We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.
The corporate bond market will probably struggle to return much above break-even in 2014.